LCA-Vision (LCAV) Shares Jump on Analyst Upgrade from Sell to Hold
More News related to LCAV
- LCA-Vision (LCAV) Reports Q3 Loss of $1.07
- LCA-Vision Reports Third Quarter Financial Results and Provides Business Update
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- American Laser Centers Names Health Care Veteran Steven Straus CEO
- LCA-Vision (LCAV) Announces CEO Resignation
More News related to Upgrades
- Shares of Brocade (BRCD) Outperforming as Oscar Gruss Upgrades to Buy
- Kinross (KGC) Jumps Higher as Gold Breaks $1,200, JPMorgan Upgrades to Overweight
- Raymond James Upgrades PSS World Medical (PSSI) to Outperform
- Capital One Southcoast Upgrades Penn Virginia (PVA) to Add; Turning Bullish After Data Release
- Raymond James Upgrades CPFL Energia S.A. (CPL) to Outperform
Following yesterday's 7% drop in shares of LCA-Vision (Nasdaq: LCAV), the stock is getting a boost today from an analyst upgrade over at Maxim Group. The firm moved its investment rating on the Lasik provider from Sell to Hold.
LCA-Vision shares most recently traded at $3.98, up 7% from yesterday's close.
To see all the analyst calls on shares of LCAV, visit our Analyst Ratings page.
Related Categories
UpgradesStocks Mentioned
+0.36Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
